Novel pharmaceutical composition for anaplastic thyroid carcinoma

Technology Showcase Offer Details
TitleNovel pharmaceutical composition for anaplastic thyroid carcinoma
Profile TypeTechnology Offer
DTK CodeTO201705
Internal ReferenceTOKR20170321001
IndustryBioChem Tech

A Korean company specialised in biomedical science has developed a new treatment for anaplastic thyroid carcinoma. The new pharmaceutical composition will enable to cure undifferentiated thyroid cancer. The company is looking for partners to make license agreement with or progress joint research and development.

Type and Role of Partner Sought

Type of partner sought

  • SME and larger company

Specific area of activity of partner

  • western medicine, oriental medicine, undifferentiated thyroid cancer

Tasks to be performed by the partner sought

  • Research cooperation and License agreement
Type of Partnership Considered

License Agreement, Research Cooperation Agreement

Technology Keywordaromatic , cancerology , chemical , cytology , drug , emergency , medicine , oncology , pharmaceutical , spices , vaccine
EEN Application FileEEN Application File TOKR20170321001.PDF

The profile provides the summary only. For the profile details, please download the application file in PDF.

 | DeltaTech-Korea Ltd

Leave your comments !

Inquiry Contact

Contact below with your service requirements



Page QR Code

Technology Requests or Offers?